BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26868347)

  • 1. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.
    Katz MS; Husain ZA
    Lancet Oncol; 2016 Feb; 17(2):e41-e42. PubMed ID: 26868347
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply.
    Chang JY; Senan S; Smit EF; Roth JA
    Lancet Oncol; 2016 Feb; 17(2):e42-e43. PubMed ID: 26868349
    [No Abstract]   [Full Text] [Related]  

  • 3. Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?
    Meyers BF; Puri V; Broderick SR; Samson P; Keogan K; Crabtree TD
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):468-71. PubMed ID: 26259993
    [No Abstract]   [Full Text] [Related]  

  • 4. [Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?].
    Guckenberger M; Andratschke N
    Strahlenther Onkol; 2015 Dec; 191(12):988-90. PubMed ID: 26459463
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgery versus SABR for resectable non-small-cell lung cancer.
    Hamaji M; Groth SS; Sugarbaker DJ; Burt BM
    Lancet Oncol; 2015 Aug; 16(8):e372. PubMed ID: 26248839
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgery versus SABR for resectable non-small-cell lung cancer.
    Opitz I; Rocco G; Brunelli A; Varela G; Massard G; Weder W;
    Lancet Oncol; 2015 Aug; 16(8):e372-3. PubMed ID: 26248838
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgery versus SABR for resectable non-small-cell lung cancer.
    Zhang L; Tian J; Wang C
    Lancet Oncol; 2015 Aug; 16(8):e371-2. PubMed ID: 26248837
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgery versus SABR for resectable non-small-cell lung cancer.
    Cao C; D'Amico T; Demmy T; Dunning J; Gossot D; Hansen H; He J; Jheon S; Petersen RH; Sihoe A; Swanson S; Walker W; Yan TD;
    Lancet Oncol; 2015 Aug; 16(8):e370-1. PubMed ID: 26248836
    [No Abstract]   [Full Text] [Related]  

  • 9. SABR in early operable lung cancer: time for evidence.
    Treasure T; Rintoul RC; Macbeth F
    Lancet Oncol; 2015 Jun; 16(6):597-8. PubMed ID: 25981817
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.
    Chang JY; Senan S; Smit EF; Roth JA
    Lancet Oncol; 2015 Aug; 16(8):e374-5. PubMed ID: 26248841
    [No Abstract]   [Full Text] [Related]  

  • 11. SABR vs surgery for NSCLC in the media.
    Rice D; Sepesi B; Heymach J; Swisher S; Vaporciyan A
    Lancet Oncol; 2015 Sep; 16(9):e422. PubMed ID: 26370343
    [No Abstract]   [Full Text] [Related]  

  • 12. Do we know bad science when we see it?
    Jones DR
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):472-3. PubMed ID: 26254751
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgery versus SABR for resectable non-small-cell lung cancer.
    Dearman C; van As N; Crellin A; Slevin N; Sharma RA
    Lancet Oncol; 2015 Aug; 16(8):e373-4. PubMed ID: 26248840
    [No Abstract]   [Full Text] [Related]  

  • 14. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
    Rosen JE; Salazar MC; Wang Z; Yu JB; Decker RH; Kim AW; Detterbeck FC; Boffa DJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):44-54.e9. PubMed ID: 27131846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit?
    Iyengar P; Lau S; Donington JS; Suh RD
    Am Soc Clin Oncol Educ Book; 2016; 35():e460-7. PubMed ID: 27249754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.
    Owen D; Siva S; Salama JK; Robinson C; Kruser TJ; Giuliani M
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):5-9. PubMed ID: 35964631
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
    Paix A; Noel G; Falcoz PE; Levy P
    Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lobectomy for local recurrence following stereotactic radiotherapy to non-small cell lung cancer].
    Neri S; Kitamura J; Komatsu T; Takahashi Y; Takeshima Y; Kaji R; Hayashi M; Nishimura T; Tomii K; Katakami N; Ishihara K; Kokubo M
    Kyobu Geka; 2009 Aug; 62(9):812-5. PubMed ID: 19670785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
    Neri S; Takahashi Y; Terashi T; Hamakawa H; Tomii K; Katakami N; Kokubo M
    J Thorac Oncol; 2010 Dec; 5(12):2003-7. PubMed ID: 21102262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
    Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
    Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.